Beth Gilbert and Lindsey Marcellin, MD, MPH

Integrated, evidence-based treatments for both PTSD and substance-use disorder are an area of unmet need.

Nonpharmacologic management with multidisciplinary teams warranted due to lack of effective pharmacologic options.

Study suggests immunotherapy may block the development and spread of Parkinson’s disease pathology in the brain.